Canine Retinal Diseases Study Guide

Overview and Clinical Importance

Retinal diseases represent a significant category of ophthalmic conditions in dogs that frequently appear on the NAVLE. The retina, a thin layer of neural tissue lining the back of the eye, is essential for converting light into electrical signals for vision. Retinal pathology can result from inherited disorders, systemic diseases, infectious agents, or vascular abnormalities. Hypertensive retinopathy is particularly important as it represents ocular target organ damage from systemic hypertension and can cause acute, irreversible blindness if not promptly diagnosed and treated.

Understanding the pathophysiology, clinical presentation, diagnosis, and management of canine retinal diseases is essential for the general practitioner, as early recognition can prevent permanent vision loss and may indicate underlying systemic disease requiring immediate intervention.

Retinal Anatomy Review

The canine retina consists of ten distinct layers. The photoreceptor layer contains rods (night vision, motion detection) and cones (day vision, color perception). The retinal pigment epithelium (RPE) provides metabolic support to photoreceptors and is critical for maintaining retinal attachment. The tapetum lucidum, located in the choroid, reflects light back through the retina to enhance vision in low-light conditions and gives the characteristic eye shine in dogs.

Progressive Retinal Atrophy (PRA)

Definition and Pathophysiology

Progressive retinal atrophy (PRA) is a group of inherited, bilateral degenerative retinal diseases characterized by progressive photoreceptor death leading to blindness. The condition is analogous to retinitis pigmentosa in humans. In most dogs, PRA is inherited as an autosomal recessive trait, meaning affected dogs must inherit defective genes from both parents.

Classification

Clinical Signs

• Nyctalopia (night blindness) - earliest sign as rods degenerate first
• Progressive loss of day vision as cones degenerate
• Dilated pupils with sluggish pupillary light reflex (PLR)
• Increased tapetal reflectivity (hyperreflectivity) on fundoscopy
• Secondary cataracts (common late-stage finding)

Fundoscopic Findings

Tapetal hyperreflectivity: As the retina thins, more light reflects from the tapetum. Vascular attenuation: Retinal blood vessels become narrowed or lost. Optic disc pallor: The optic nerve head appears pale or atrophied. Nontapetal depigmentation: Decreased pigmentation in the ventral nontapetal fundus with patchy hyperpigmentation.

Diagnosis

Treatment and Prognosis

No effective treatment exists for PRA. Antioxidant supplements (Ocu-GLO) may help delay secondary cataract formation but do not prevent photoreceptor degeneration. Gene therapy is experimental and limited to research settings. Affected dogs and their parents/siblings should be removed from breeding programs. Most dogs adapt well to blindness using other senses.

Sudden Acquired Retinal Degeneration Syndrome (SARDS)

Definition and Pathophysiology

SARDS is a disease causing rapid, permanent blindness due to acute photoreceptor degeneration. Unlike PRA, SARDS is acquired (not inherited) and the exact cause remains unknown. Proposed mechanisms include autoimmune attack on photoreceptors and neuroendocrine dysfunction. Many dogs with SARDS have concurrent metabolic abnormalities resembling Cushing's disease.

Signalment and Risk Factors

• Average age: 7-10 years (middle-aged to older dogs)
• Sex predisposition: Spayed females more commonly affected
• Breeds: Dachshund, Miniature Schnauzer, Pug, Beagle, Bichon Frise, Cocker Spaniel, Maltese; also common in mixed breeds
• Seasonality: Nearly 50% of cases diagnosed in December-January

Clinical Signs

Acute blindness developing over days to weeks (most complete within 2 weeks). Dogs bump into objects, appear disoriented, or stand in place. Mydriatic pupils with sluggish to absent PLR. Absent dazzle reflex (no blink response to bright light). Many dogs show concurrent systemic signs: polyphagia, polydipsia, polyuria, and weight gain.

Diagnosis

Differential Diagnosis: SARDS vs. Optic Neuritis

Both cause acute blindness with normal-appearing fundus initially. ERG distinguishes them: SARDS has FLAT ERG (retina non-functional), while optic neuritis has NORMAL ERG (retina functional but signal cannot reach brain). This differentiation is critical as optic neuritis may respond to immunosuppressive therapy.

Treatment and Prognosis

No proven effective treatment exists. Immunosuppressive therapy has been attempted with controversial and inconsistent results. IVIg (intravenous immunoglobulin) has shown limited success in experimental settings. Blindness is permanent. However, most dogs adapt well: 80% of owners report moderate to excellent quality of life. Secondary cataracts may develop months to years after diagnosis.

Hypertensive Retinopathy and Choroidopathy

Definition and Pathophysiology

Hypertensive retinopathy is ocular target organ damage resulting from systemic hypertension. When systolic blood pressure exceeds approximately 180 mmHg, the delicate retinal and choroidal blood vessels become damaged. The pathophysiology involves initial arteriolar vasoconstriction, followed by breakdown of the blood-retinal barrier, vascular leakage, hemorrhage, and ultimately retinal detachment.

Causes of Systemic Hypertension in Dogs

Clinical Signs

Acute blindness is often the presenting complaint, as owners notice their dog bumping into furniture or showing reluctance to navigate in unfamiliar environments. Vision loss may be sudden or progressive depending on the severity and duration of hypertension.

• Dilated, poorly responsive pupils (unilateral or bilateral)
• Hyphema (blood in anterior chamber)
• Retinal hemorrhages (most common finding - 40% of hypertensive dogs)
• Retinal detachment (appears as gray veil behind lens)
• Tortuous retinal vessels ("box-carring" or sausage-link appearance)
• Subretinal edema/fluid (appears as out-of-focus patches in tapetal fundus)

Fundoscopic Findings

Diagnosis and Workup

Blood pressure measurement is essential. Use Doppler or oscillometric methods. Systolic BP greater than 160 mmHg is hypertensive; greater than 180 mmHg indicates high risk for target organ damage. Obtain multiple measurements to account for "white coat" effect.

• Complete ophthalmic examination including indirect ophthalmoscopy, tonometry, fundoscopy
• CBC and serum chemistry (evaluate for kidney disease, diabetes)
• Urinalysis with UPC ratio (assess kidney function, proteinuria)
• Thyroid panel (rule out hypothyroidism)
• ACTH stimulation or LDDS (if Cushing's suspected)
• Abdominal ultrasound (evaluate kidneys, adrenal glands)

Treatment

Prognosis

Prognosis for vision recovery depends on severity and duration of retinal damage. Partial to complete retinal detachment carries a guarded to poor visual prognosis. If blood pressure is controlled promptly before ischemic damage occurs, subretinal fluid may resorb and the retina may reattach with some return of vision. Complete detachments with significant hemorrhage are associated with permanent blindness. Lifelong BP monitoring and treatment are required.

Retinal Detachment

Classification

Retinal detachment occurs when the neurosensory retina separates from the underlying retinal pigment epithelium. Classification is based on mechanism:

Clinical Signs and Diagnosis

• Vision loss (may be subtle if partial/unilateral)
• Dilated pupil with absent or sluggish PLR
• Gray floating membrane visible behind lens
• Fundoscopy: Elevated, undulating, out-of-focus retina; gravity causes inferior pooling
• Ocular ultrasound: Essential when media opacity prevents fundoscopy; shows characteristic "seagull wing" pattern

Chorioretinitis

Definition

Chorioretinitis is inflammation of the choroid and retina, often secondary to systemic infectious disease. The choroid's highly vascular nature makes it susceptible to hematogenous spread of pathogens. Chorioretinitis is an important diagnostic clue for systemic disease.

Infectious Causes

Non-Infectious Causes

• Immune-mediated: Uveodermatologic syndrome (VKH-like), autoimmune retinopathy
• Neoplastic: Metastatic tumors, lymphoma, histiocytic sarcoma
• Trauma: Usually involves entire eye, not isolated chorioretinitis

Fundoscopic Appearance

Active lesions: Hyporeflective (darker than normal tapetum), ill-defined borders, hazy appearance, perivascular cuffing. Inactive/healed lesions: Hyperreflective (brighter) scars with increased pigmentation, well-defined borders. The presence of scars indicates previous inflammation.